SAN MATEO, Calif., Aug. 9, 2011 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON) will host a conference call on Monday, August 15, 2011 at 8:30AM PT, to include a discussion of results and highlights of the second quarter and a business update.
Conference call details:
| Date: | Monday, August 15, 2011 |
| Time: | 11:30am ET, 8:30am PT |
| Dial-in (U.S. and Canada): | (877) 681 – 1326 |
| Dial-in (International): | (708) 290 – 1158 |
| Web cast: | www.talontx.com |
An archived version of the webcast will also be available via the company's website following the call.
About Talon Therapeutics, Inc.
Talon Therapeutics, Inc. is a biopharmaceutical company dedicated to developing and commercializing new, differentiated cancer therapies designed to improve and enable current standards of care. Talon is developing its lead product candidate, Marqibo, primarily for the treatment of acute lymphoblastic leukemia and lymphomas. The Company has additional pipeline opportunities some of which, like Marqibo, are designed to improve delivery and enhance the therapeutic benefits of well characterized, proven chemotherapies and enable high potency dosing without increased toxicity. Additional information on Talon Therapeutics can be found at www.talontx.com
The Talon Therapeutics, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3290